Pfizer begins developing pill for Covid positive patients

Pfizer/BioNTech is carrying out clinical trials to develop a pill for Covid-19 patients.

It appears that there is hope for those who end up infected by Covid-19 as Pfizer/BioNTech is carrying out clinical trials to create a pill for those who develop symptoms.

If this works, the patients’ symptoms may be controlled and not allowed to get worse, with the patient possibly ending up at risk of death.

Pfizer’s main official, Mikael Dolsten, said that this new technology will complement the vaccination which gives hope during this pandemic, as the virus and the variants have continued to mutate and spread.

The pill works by stopping the virus from replicating itself in a person’s cells.